Galapagos plans to form a strategic partnership with Gilead after Gilead purchased Ouro Medicines. The acquisition of Ouro Medicines by Gilead has prompted Galapagos to consider a collaboration. This move comes as part of Galapagos' strategic business decision. This collaboration is expected to involve significant resources and potentially provide a boost to both companies. The exact terms of the partnership and the financial implications are not disclosed as of now. Stay tuned for further updates on this developing collaboration.